Otsuka Pakistan Limited (PSX:OTSU)
326.19
+6.22 (1.94%)
At close: Oct 21, 2025
Otsuka Pakistan Revenue
In the fiscal year ending June 30, 2025, Otsuka Pakistan had annual revenue of 3.78B PKR with 19.46% growth. Otsuka Pakistan had revenue of 1.11B in the quarter ending June 30, 2025, with 8.52% growth.
Revenue
3.78B
Revenue Growth
+19.46%
P/S Ratio
1.04
Revenue / Employee
9.26M
Employees
408
Market Cap
3.95B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 3.78B | 615.65M | 19.46% |
Jun 30, 2024 | 3.16B | 128.78M | 4.24% |
Jun 30, 2023 | 3.04B | 183.35M | 6.43% |
Jun 30, 2022 | 2.85B | 305.46M | 12.00% |
Jun 30, 2021 | 2.55B | 319.29M | 14.34% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Abbott Laboratories (Pakistan) | 72.39B |
GlaxoSmithKline Pakistan | 62.62B |
The Searle Company | 28.60B |
Shifa International Hospitals | 27.97B |
AGP Limited | 26.11B |
Highnoon Laboratories | 25.78B |
Ferozsons Laboratories | 18.86B |
Citi Pharma | 13.15B |